The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)

Clinical trial NCT04389671 · COMPLETED

Trial details

NCT number: NCT04389671
Sponsor: Windtree Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)

Start date: 2021-01-05
Primary completion: 2022-02-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.